Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04564196 · ClinicalTrials.gov registry record
Breath Metabolomics in the Laboring Parturient
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 53
- Enrollment target
NCT04564196: Clinical Trial study, sponsored by Stanford University.
NCT04564196 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04564196 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 53 participants
- Enrollment target
Study Summary
This is primarily a feasibility study to determine whether quantitative measurement of volatile organic compounds (VOCs) in the breath of parturients undergoing labor is possible. Aim A: To determine baseline values of breath metabolites and volatile organic compounds (VOCs) in the breath for term pregnant women. Aim B: To gather preliminary data to determine breath metabolite and volatile organic compound (VOCs) signature change during labor and delivery. Aim C: Compare the breath metabolite and volatile organic compound (VOCs) signature women undergoing induction compared to spontaneous vaginal deliveries.
Primary Outcome
Mass spectrometry analysis of volatile organic compounds of the breath
Interventions
- PROCEDURE Breath Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-11-11 |
| Est. Completion | 2023-06-06 |
Why NCT04564196 stopped before completion
NCT04564196 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Breath Sample is the first listed.
NCT04564196 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04564196 about?
NCT04564196 is a clinical study titled "Breath Metabolomics in the Laboring Parturient". This is primarily a feasibility study to determine whether quantitative measurement of volatile organic compounds (VOCs) in the breath of parturients undergoing labor is possible. Aim A: To determine baseline values of breath metabolites and volatile organic compounds (VOCs) in the breath for term ...
What is the current status of trial NCT04564196?
This trial is currently terminated. The enrollment target is 53 participants. The study started on 2020-11-11. Estimated completion is 2023-06-06.
What interventions are being tested in trial NCT04564196?
The interventions under investigation include: Breath Sample (PROCEDURE).
Who is sponsoring clinical trial NCT04564196?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI